These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 24403009)
1. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Barbui C; Conti V; Cipriani A Drug Saf; 2014 Feb; 37(2):79-90. PubMed ID: 24403009 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis. Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363 [TBL] [Abstract][Full Text] [Related]
3. The Association and Influencing Factors between Antipsychotics Exposure and the Risk of VTE and PE: A Systematic Review and Meta-analysis. Dai L; Zuo Q; Chen F; Chen L; Shen Y Curr Drug Targets; 2020; 21(9):930-942. PubMed ID: 32321400 [TBL] [Abstract][Full Text] [Related]
4. Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis. Di X; Chen M; Shen S; Cui X Psychiatry Res; 2021 Feb; 296():113691. PubMed ID: 33421839 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies. Nosè M; Recla E; Trifirò G; Barbui C Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):812-20. PubMed ID: 26017021 [TBL] [Abstract][Full Text] [Related]
6. Association of Antipsychotic Drugs with Venous Thromboembolism: Data Mining of Food and Drug Administration Adverse Event Reporting System and Mendelian Randomization Analysis. Li T; Hu K; Ye L; Ma J; Huang L; Guo C; Huang X; Jiang J; Xie X; Guo C; He Q J Atheroscler Thromb; 2024 Apr; 31(4):396-418. PubMed ID: 38030236 [TBL] [Abstract][Full Text] [Related]
7. Fatal pulmonary embolism in patients on antipsychotics: case series, systematic review and meta-analysis. Manoubi SA; Boussaid M; Brahim O; Ouanes S; Mahjoub Y; Zarrouk L; Mesrati MA; Aissaoui A Asian J Psychiatr; 2022 Jul; 73():103105. PubMed ID: 35452966 [TBL] [Abstract][Full Text] [Related]
8. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism. Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035 [TBL] [Abstract][Full Text] [Related]
9. Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies. Liu Y; Xu J; Fang K; Xu Y; Gao J; Zhou C; Tang X; Fang X; Chen J; Xie C; Zhang F; Zhang X; Wang C Ther Adv Psychopharmacol; 2021; 11():2045125320982720. PubMed ID: 33505665 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotics and venous thromboembolism risk: a meta-analysis. Zhang R; Dong L; Shao F; Tan X; Ying K Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies. Papola D; Ostuzzi G; Thabane L; Guyatt G; Barbui C Int Clin Psychopharmacol; 2018 Jul; 33(4):181-196. PubMed ID: 29688914 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Ishiguro C; Wang X; Li L; Jick S Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779 [TBL] [Abstract][Full Text] [Related]
13. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Kunutsor SK; Seidu S; Khunti K Ann Med; 2018 Sep; 50(6):529-537. PubMed ID: 30001640 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study. Mollard LM; Le Mao R; Tromeur C; Le Moigne E; Gouillou M; Pan-Petesch B; Delluc A; Couturaud F; Lacut K Eur J Intern Med; 2018 Jun; 52():22-27. PubMed ID: 29548526 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
16. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765 [TBL] [Abstract][Full Text] [Related]
17. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study. Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665 [TBL] [Abstract][Full Text] [Related]
18. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis. Ho KM; Bham E; Pavey W J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150 [TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. Jönsson AK; Spigset O; Hägg S CNS Drugs; 2012 Aug; 26(8):649-62. PubMed ID: 22731933 [TBL] [Abstract][Full Text] [Related]
20. The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study. Ferraris A; Szmulewicz AG; Posadas-Martínez ML; Serena MA; Vazquez FJ; Angriman F J Clin Psychiatry; 2019 Aug; 80(5):. PubMed ID: 31509358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]